Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Safety Funding Boost Means Cuts Elsewhere In CDER

Executive Summary

FDA's fiscal year 2006 budget request proposes to cut 55 positions at the Center for Drug Evaluation & Research from outside its user fee and drug safety functions

You may also be interested in...



FDA Budget Targets CBER For Pandemic Funds, Creates Flu Strain Library

FDA is highlighting development of a library of flu strains as a key component of its request to fund pandemic preparedness at $30.5 mil. in fiscal year 2007

FDA Budget Targets CBER For Pandemic Funds, Creates Flu Strain Library

FDA is highlighting development of a library of flu strains as a key component of its request to fund pandemic preparedness at $30.5 mil. in fiscal year 2007

Conflict Of Interest Waivers Would Be Barred For FDA Cmtes. Under Bill

FDA would effectively be barred from granting financial conflict of interest waivers for advisory committee members under the fiscal year 2006 House agriculture appropriations bill

Related Content

Topics

UsernamePublicRestriction

Register

OM008605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel